Nausea and Vomiting in Pregnancy
Contents
- 1 Risk factors for nausea and vomiting of pregnancy are all except
- 2 Pathogenesis of NVP involves all except
- 3 Hyperemesis gravidarum (HG) can cause all of the pathological changes except
- 4 Biomarkers for HG are all except
- 5 The newly introduced resurgent therapy Diclegis for for nausea and vomiting in pregnancy is a combination of
- 6 Which of the following antiemetic is a pregnancy C category drug
- 7 In shorts
Risk factors for nausea and vomiting of pregnancy are all except
A. History of migraine headaches
B. Helicobacter pylori (H. pylori) infection
C. Corpus luteum present in the right ovary
D. Smoking before pregnancy
Pathogenesis of NVP involves all except
A. Excess of chorionic gonadotropin or higher biological activity of hCG
B. Ovarian hormones, estrogen and progesterone
C. Thyroid-stimulating hormone
D. Placental prostaglandin E2
Hyperemesis gravidarum (HG) can cause all of the pathological changes except
A. Subendocardial hemorrhage
B. Fatty infiltration of liver with necrosis
C. Pneumomediastinum
D. Fatty change in the cells of first convoluted tubule
Biomarkers for HG are all except
A. Ketonuria
B. High TWBC
C. Low urinary chloride
D. Hemodilution
The newly introduced resurgent therapy Diclegis for for nausea and vomiting in pregnancy is a combination of
A. 10 mg doxylamine succinate and 10 mg pyridoxine HCl
B. 10 mg metoclopramide in combination with pyroxamine
C. 8mg Zofran with 10 mg pyridoxine HCl
D. 15 mg Mirtazapine with 10 mg metoclopramide
Which of the following antiemetic is a pregnancy C category drug
A. Metoclopramide
B. Promethazine
C. Ondansetron
D. Doxylamine
In shorts
- Clonidine, a centrally acting alpha-agonist, is commonly utilized as an antihypertensive agent; however, it has also been referenced in treatment of patients with refractory hyperemesis gravidarum.
- Metoclopramide is supplied with a “black box” warning of possible irreversible tardive dyskinesia and is absolutely contraindicated in patients who are taking other medications with possible extrapyramidal effects. It is currently rated as pregnancy category B agent.
- Zofran does not promote gastrointestinal motility and is therefore an agent of choice in cases of emesis and diarrheal symptoms. It is not recommended in cases of nausea where gastroparesis or ileus may be a concern.
- Mirtazapine has been found to be specifically beneficial in cases of hyperemesis gravidarum compounded by a psychiatric diagnosis such as depression
